Emcure Pharma IPO: In the share market, many companies are listing and collecting funding through the share. If a company wants to become a public company and offer a company share price for publically first time.
In this condition, it first offers the IPO (Initial public offer) to attract the investor to invest in the company and enter the share market. After the IPO company did not come under the private owner and investors.
In this blog, we will discuss the upcoming Emcure Pharma IPO and its related important points and facts. Let’s delve into the article and learn more about this.
Objectives of Emcure Pharma IPO
If we talk about the main objective of the Emcure Pharma Limited IPO then through the IPO company wants to collect the funds of amount Rs 1952.03 Crore and come into the share market.
Due to this IPO company issued an amount is Rs 800 Crore fresh shares which is quantity 796507.
Apart from this company sold the amount of Rs 1152.03 crore Shares through the “Offer for Sale” (OFS). The quantity of these shares is 11428839.
Also Read: Alok Industries Share Price 2024
Emcure Pharma IPO Structure
- If we talk about the IPO Structure then through the IPO person can bid for a maximum of 196 shares. For these share price band amount is decided at Rs 960 to Rs 1008.
- A person can be bidding for a Minimum of 14 Shares.
- To apply through the upper bidding (Rs 1008) then you have to pay the amount of Rs 14112 for one lot of shares.
- To apply the maximum lot (13 lot) which comes to 196 Shares you have to pay the amount according to the upper price of Rs 197568.
| Reserved Offer | Percentage |
| Qualified institutional Buyers | 50% |
| Retail investors | 35% |
| Institutional investors | 15% |
| Website | Economictimes.com |
Book-running leads managers of Emcure Pharma IPO
- Kotak Mahindra Capital
- Axis Capital
- Jefferies
- JP Morgan india
Other necessary Points related to the IPO
- To apply for the Emcure Pharma IPO you can start the bidding on 3 July 2024.
- The close date of the Emcure Pharma IPO is decided on 5 July 2024.
- The Share allotment date is 8 July 2024.
- If a person is not allowed an IPO share, it is refunded on 9 July 2024.
- If a person is allotted an IPO share then it’s credited on 9 July 2024 on their demat account.
- The shares are listed on the market on 10 July 2024.
News highlight of Emcure Pharma
- The premium price of Emcure Pharma has increased and gone 26.88% before the open its IPO.
- The premium price (GMP)of Emcure Pharma is Rs 271 per share.
- In the share, Emcure Pharma reserves some amount of shares for their company-eligible employees. the quantity of the reserved shares is 108900 shares. Apart from this company gives a discount for their employees on the purchase of these shares the discount is Rs 90 per share.
Financial Performance of the Emcure Pharma
In the Year 2024 company’s total revenue was Rs 6715.24 crore. In which total assets were Rs 7806.16 Crore and gained a total profit of Rs 527.58 Crore.
In the Year 2023 Company’s total revenue was Rs 6031.72 Crore. In which total assets were Rs 6672.53 Crore and gained a total profit of Rs 561.85 Crore.
In the Year 2022 Company’s total revenue was Rs 5918.86 Crore. In which total assets were Rs 6063.47 Crore and gained a total profit of Rs 702.56 Crore.
| Year | Revenue (Crore) | Networth (Crore) |
| 2024 | Rs 6715.24 | Rs 2952.28 Cr |
| 2023 | Rs 6031.72 | Rs 2501.13 Cr |
| 2022 | Rs 5918.86 | Rs 1987.55 Cr |
Brief Introduction of the Emcure Pharma
Emcure Pharma is an Indian-based multinational private-sector company Established in 1981 by Mr. Satish Mehta. This company comes under the Pharmaceuticals sector in India.
It also manufactures pharma products like nephrology, HIV, Anti-infectives, generic drugs, and many other products.
Apart from this, Emcure Pharma has many research & Development (R&D) Labs. The company’s value in the Indian market is Rs 19,000 crore.
In india Emcure Pharma has 13 manufacturing Plants in which it manufactures biopharmaceutical products like liquid substances, tablets, injections, and many other products.
Apart from this, it has 5 Research facilities in india in which more than 500 scientists are working in research and development.
If we talk about its international business then its have business worldwide in 70+ countries along with india. The company’s headquarters is located in Hinjawadi, Pune, India.
Important key People
- CEO & MD: Satish Mehta
- Chairman: Berjis Desai
- Executive Director: Sunil Mehta
- Executive Director: Namita Thapar
Conclusion
In this blog, we will completely cover the topic of Emcure Pharma IPO and its related important facts. If you are planning to invest in this IPO then must apply before 5 July 2024. Many platforms are available to apply for this Emcure pharma IPO.
If you have suggestions related to this article then drop your suggestion into the comment box.
What is the valuation of Emcure?
The Current market value of Emcure Pharma is Rs 19000 Crore.
Who is the co-founder of Emcure Pharma?
Mr. Satish Mehta is a co-founder of Emcure Pharma.
What is the Emcure Pharma IPO structure?
As per IPO, Qualified Institutional Buyers are reserved for 50%, Retail investors are reserved for 35%, and Non-Institutional investors are reserved for 15% of the bidding for the IPO.
What is the rank of Emcure Pharmaceuticals Ltd in India?
As per AWACS MAT, february 2024 report Emcure Pharma is the 11th largest pharmaceutical company in india.
Is Emcure a big company?
Yes, Emcure Pharma is indian based multinational company that has been working with 70+ countries along with india. In india its have 31 manufacturing plants and 5 research facilities.
Exciting times ahead with Emcure Pharma’s IPO! Their strong market presence and innovative products make it a promising investment opportunity. I’m looking forward to seeing what this turns out to be!